Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
    Acute Liver Failure Alcohol-Associated Liver Disease Autoimmune Hepatitis Career Development and Mentorship Cholestatic Liver Disease Complications of Liver Disease and Portal Hypertension Drug-Induced Liver Disease HepMadness Inherited Disorders Liver Anatomy, Development, and Physiology Liver Infections Liver Physiology Liver Related Infections MASLD/MASH Neoplasms of the Liver Pathology Pediatrics Pregnancy-Related Liver Disease Symptoms and Clinical Presentation of Liver Disease and Portal HTN Systemic Conditions with Hepatic Manifestations Transplantation and Surgery Vascular Viral Hepatitis
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Podcast The Why? Series Tools of the Trade View All Core Series Practice Questions
  • Tweetorials
  • About

Posts by Chip Bowman

Chip Bowman

Chip Bowman

Content Writer

@ChipSBowman
The Why? Series

Why machine perfusion has the potential to change the liver transplant landscape - and why hasn’t it yet?

Why has liver transplantation grown significantly in recent decades? Orthotopic liver transplantation (OLT) has been performed since 1963 with more routine application being used starting since the...

Chip Bowman

Chip Bowman

January 17, 2025
The Why? Series

Why do we care about frailty in liver disease?

Frailty is a prevalent complication of end-stage liver disease and is characterized by decreased physiologic reserve and increased vulnerability to health stressors. The concept of frailty matters in...

Chip Bowman

Chip Bowman

June 5, 2024
The Why? Series

What’s the deal with viral hepatitis vaccination?

Viral hepatitis has been and remains a formidable global health challenge. To effectively combat this, we employ a powerful tool: vaccinations. In this discussion, we will delve into the intricacies...

Chip Bowman

Chip Bowman

December 6, 2023

Subscribe

Enter your email here and receive monthly newsletters with new LFN material.

Registration failed. Please try again later.

Thanks for signing up!

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2025 American Association for the Study of Liver Diseases